REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Genor Biopharma Holdings Limited (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Genor Biopharma Holdings Limited Profile Updated: October 28, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

JHBP CY Holdings Limited focuses on the development and commercialization of drugs for oncology and autoimmune diseases. The company provides drugs for the treatment of breast cancer, cervical cancer, pancreatic cancer and other cancer diseases. The company was established in 2017 and headquartered in Shanghai City, China.

Headquarters
Building 3, 1690 Zhangheng Road, Pudong New District
Shanghai; Shanghai; Postal Code: 201203

Contact Details: Purchase the Genor Biopharma Holdings Limited report to view the information.

Website: http://www.genorbio.com

Basic Information
Total Employees:
Purchase the Genor Biopharma Holdings Limited report to view the information.
Outstanding Shares:
Purchase the Genor Biopharma Holdings Limited report to view the information.
Registered Capital:
Purchase the Genor Biopharma Holdings Limited report to view the information.
Financial Auditors:
Purchase the Genor Biopharma Holdings Limited report to view the information.
Incorporation Date:
April 10, 2017
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
24.56%
Purchase this report to view the information.
7.31%
Purchase this report to view the information.
5.67%
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Genor Biopharma (Hk) Limited (Hong Kong SAR, China)
100%
Genor Biopharma (Usa), Inc (United States)
100%
Ab Therapeutics Inc. (Abt) (United States)
80%
Company Performance
Financial values in the chart are available after Genor Biopharma Holdings Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Total operating revenue
503.71%▲
Operating profit (EBIT)
56.02%▲
EBITDA
55.2%▲
Net Profit (Loss) for the Period
54.09%▲
Total assets
-30.54%▼
Total equity
-32.1%▼
Return on Equity (ROE)
5.68%▲
Debt to Equity Ratio
-1.85%▼
Quick Ratio
-0.78%▼
Cash Ratio
-0.78%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo